Novo Nordisk says Ozempic helped patients with Type 2 diabetes in one new way
Novo Nordisk A.S. said Tuesday a five-year trial of its Ozempic weight-loss drug helped reduce the risk of kidney disease-related ...
Read moreNovo Nordisk A.S. said Tuesday a five-year trial of its Ozempic weight-loss drug helped reduce the risk of kidney disease-related ...
Read moreBladder-cancer treatment developer CG Oncology filed for an initial public offering with the Securities and Exchange Commission. The Irvine, Calif.-based ...
Read moreWuxi XDC Cayman’s shares rose in their trading debut in Hong Kong as investors scrambled to compensate for the lost ...
Read moreThe stock of Cargo Therapeutics CRGX, +2.80%, a clinical-stage biotech specializing in cancer treatments, rose 2.2% in its trading debut ...
Read moreMallinckrodt PLC said Wednesday it will file for chapter 11 bankruptcy protection in the coming days — its second such ...
Read moreBetter Therapeutics Inc. shares surged in the extended session Monday after the digital therapeutics company got Food and Drug Administration ...
Read moreEli Lilly & Co. said Thursday it has agreed to acquire Sigilon Therapeutics Inc. in a deal worth up to ...
Read moreEisai shares 4523, +7.37% rose sharply Thursday morning after the U.S. Food and Drug Administration’s review memo on Leqembi raised ...
Read moreAstellas Pharma Inc. said Monday that it agreed to acquire Iveric bio Inc. for about $5.9 billion to strengthen its ...
Read moreThis copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or ...
Read moreTodayheadline the independent news and topics discovery
A home-grown and independent news and topic aggregation . displays breaking news linking to news websites all around the world.
© 2024 All rights are reserved Today Headline